European Medicines Agency
Silvy da Rocha Dias joined the European Medicines Agency (EMA) in 2007. Prior to this, she built a strong academic career as a researcher at several prestigious institutions in the Netherlands, the United States, and the United Kingdom, initially in the field of immunology before transitioning to oncology, with a focus on melanoma drug development. At the EMA, she spent several years as a Product Lead within the Oncology, Haematology and Diagnostics Office, working closely with the Agency’s scientific Committees. Since 2022, she has served as Head of the Office of Expert Panels and Groups, leading the implementation of activities related to the Expert Panels under the MDR and IVDR.
Conversations That Matter: Interactions with Health Authorities
Wednesday, May 6, 2026
16:45 - 18:00 WEST
Orphan Devices - Finding Rarity: A Case Study in Achieving Orphan Device Designation in the EU
Thursday, May 7, 2026
12:00 - 13:00 WEST
European Regulatory System for Medicines - Any Question Goes
Thursday, May 7, 2026
16:45 - 17:45 WEST